MYCN and neuroblastoma: Tissue diagnosis is required to confirm the diagnosis of neuroblastoma and to perform molecular studies to establish risk group status including: histology, grade of tumor differentiation, MYCN amplification status, and chromosomal aberrations of the tumor [3].